We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
TETRA Technologies
TTI
$1.07B
| $1.12M | ﹤0.01% |
333,610
-18,774
| -5% | -$74.9K |
|
552
Alcoa
AA
$11.7B
| $1.11M | ﹤0.01% |
36,344
-463,689
| -93% | -$16.2M |
|
553
indie Semiconductor
INDI
$678M
| $1.11M | ﹤0.01% |
543,838
-18,897
| -3% | -$65.7K |
|
554
Teradata
TDC
$2.75B
| $1.1M | ﹤0.01% |
48,790
+36,369
| +293% | +$984K |
|
555
Orion Group Holdings
ORN
$485M
| $1.1M | ﹤0.01% |
209,443
+126,397
| +152% | +$884K |
|
556
Rithm Capital
RITM
$5.46B
| $1.1M | ﹤0.01% |
95,634
+3,685
| +4% | +$42.6K |
|
557
Restaurant Brands International
QSR
$26B
| $1.09M | ﹤0.01% |
19,872
-31,146
| -61% | -$2.01M |
|
558
RH
RH
$3.36B
| $1.07M | ﹤0.01% |
+4,557
| New | +$1.58M |
|
|
SRTA
559
Strata Critical Medical Inc
SRTA
$440M
| $1.06M | ﹤0.01% |
387,609
+181,819
| +88% | +$652K |
|
560
Fluor
FLR
$6.89B
| $1.05M | ﹤0.01% |
29,399
+3,098
| +12% | +$134K |
|
561
Willis Towers Watson
WTW
$29.9B
| $1.01M | ﹤0.01% |
2,989
-1,693
| -36% | -$552K |
|
|
SEI
562
Solaris Energy Infrastructure
SEI
$2.9B
| $1.01M | ﹤0.01% |
46,338
-15,812
| -25% | -$438K |
|
563
International General Insurance
IGIC
$1.23B
| $993K | ﹤0.01% |
37,758
+4,096
| +12% | +$104K |
|
564
Tidewater
TDW
$3.71B
| $984K | ﹤0.01% |
23,281
+2,145
| +10% | +$107K |
|
565
Flutter Entertainment
FLUT
$18.9B
| $966K | ﹤0.01% |
+4,359
| New | +$1.13M |
|
566
Fiverr
FVRR
$417M
| $963K | ﹤0.01% |
+40,680
| New | +$1.18M |
|
567
Peabody Energy
BTU
$2.83B
| $938K | ﹤0.01% |
+69,207
| New | +$1.11M |
|
568
Greenlight Captial
GLRE
$586M
| $936K | ﹤0.01% |
69,065
+2,676
| +4% | +$36.4K |
|
|
VSXY
569
Victoria's Secret
VSXY
$7.1B
| $912K | ﹤0.01% |
+49,061
| New | +$1.44M |
|
570
America Movil
AMX
$77.2B
| $900K | ﹤0.01% |
63,285
-91,224
| -59% | -$1.31M |
|
571
Intercorp Financial Services
IFS
$6.44B
| $892K | ﹤0.01% |
26,917
+1,045
| +4% | +$32.8K |
|
572
Cushman & Wakefield Ltd
CWK
$3.2B
| $889K | ﹤0.01% |
87,020
+39,779
| +84% | +$484K |
|
573
Rimini Street
RMNI
$453M
| $883K | ﹤0.01% |
+253,755
| New | +$822K |
|
|
GRVY
574
GRAVITY
GRVY
$431M
| $879K | ﹤0.01% |
14,525
+749
| +5% | +$44.8K |
|
575
Hillman Solutions
HLMN
$1.6B
| $874K | ﹤0.01% |
+99,464
| New | +$966K |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.